HIGHLIGHTS
- who: Agata Bu0142aszczuk and colleagues from the SARS Laboratory, Department of Virology, Medical University of Lublin, Lublin, Poland have published the Article: Humoral Response after SARS-CoV-2 Vaccination in Prostate Cancer Patients, in the Journal: Vaccines 2023, 770 of 10/Oct/2022
- what: The authors determined the level and prevalence of antibodies against SARS-CoV-2 IgG in patients with prostate cancer compared to the control group and whether the patients` ages affected the level of antibodies. This study demonstrated lower levels of all types of antibodies in PCa patients compared to controls.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.